Legend Biotech (Legend Biotech) Other Long-Term Liabilities : $0.1 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Legend Biotech Other Long-Term Liabilities?

Legend Biotech's other long-term liabilities for the quarter that ended in Dec. 2023 was $0.1 Mil.

Legend Biotech's quarterly other long-term liabilities declined from Jun. 2023 ($0.2 Mil) to Sep. 2023 ($0.1 Mil) and declined from Sep. 2023 ($0.1 Mil) to Dec. 2023 ($0.1 Mil).

Legend Biotech's annual other long-term liabilities declined from Dec. 2021 ($0.4 Mil) to Dec. 2022 ($0.2 Mil) and declined from Dec. 2022 ($0.2 Mil) to Dec. 2023 ($0.1 Mil).

Legend Biotech Other Long-Term Liabilities Historical Data

The historical data trend for Legend Biotech's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Legend Biotech Other Long-Term Liabilities Chart

Legend Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Legend Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Legend Biotech Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Legend Biotech Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Legend Biotech's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Legend Biotech (Legend Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Legend Biotech Corp (NAS:LEGN) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

9LB:Germany

Address

2101 Cottontail Lane, Somerset, NJ, USA, 08873

Website

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.